Invention Grant
- Patent Title: Amide prodrugs of small molecule nuclear receptor modulators
-
Application No.: US16971171Application Date: 2019-02-26
-
Publication No.: US11613517B2Publication Date: 2023-03-28
- Inventor: Thomas S. Scanlan , Skylar J. Ferrara
- Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
- Applicant Address: US OR Portland
- Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
- Current Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
- Current Assignee Address: US OR Portland
- Agency: Kilpatrick Townsend & Stockton LLP
- International Application: PCT/US2019/019576 WO 20190226
- International Announcement: WO2019/168842 WO 20190906
- Main IPC: C07C235/34
- IPC: C07C235/34 ; C07C235/20 ; C07C233/65 ; C07C233/25 ; C07C233/05 ; C07C309/66 ; C07C309/41 ; C07D261/20 ; C07D277/26 ; C07D409/06 ; A61P25/00
Abstract:
Provided herein are novel amide prodrug forms of pharmaceutically active agents useful for central nervous system disorders.
Public/Granted literature
- US20210087137A1 AMIDE PRODRUGS OF SMALL MOLECULE NUCLEAR RECEPTOR MODULATORS Public/Granted day:2021-03-25
Information query
